We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

89 hedge funds and large institutions have $773M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

149% more capital invested

Capital invested by funds: $310M → $773M (+$463M)

95% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 19

25% more funds holding

Funds holding: 71 → 89 (+18)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
89
Holders Change
+18
Holders Change %
+25.35%
% of All Funds
2.37%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
37
Increased
22
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.7M
2
DM
Deerfield Management
New York
+$12.8M
3
BFA
BlackRock Fund Advisors
California
+$10.6M
4
Jennison Associates
Jennison Associates
New York
+$8.97M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$8.64M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$7.57M
2
VAM
Visium Asset Management
New York
-$4.71M
3
Millennium Management
Millennium Management
New York
-$3.77M
4
EA
Emerald Advisers
Pennsylvania
-$2.8M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$214M +$42.7M +1,452,504 +55%
DM
2
Deerfield Management
New York
$155M +$12.8M +436,943 +17%
Millennium Management
3
Millennium Management
New York
$54.5M -$3.77M -128,521 -11%
Franklin Resources
4
Franklin Resources
California
$33.5M -$1.05M -35,893 -5%
BFA
5
BlackRock Fund Advisors
California
$30.6M +$10.6M +361,670 +164%
Jennison Associates
6
Jennison Associates
New York
$29.4M +$8.97M +305,499 +120%
Vanguard Group
7
Vanguard Group
Pennsylvania
$22.7M +$2.04M +69,507 +19%
WSA
8
Wall Street Associates
California
$22.7M -$85.2K -2,900 -0.7%
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$22.3M +$8.64M +294,139 +225%
KCM
10
Kingdon Capital Management
New York
$21.1M -$666K -22,679 -5%
JP Morgan Chase
11
JP Morgan Chase
New York
$15M -$858K -29,232 -9%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$10.9M +$2.27M +77,467 +60%
Ameriprise
13
Ameriprise
Minnesota
$9.67M -$7.57M -257,636 -58%
FCMI
14
Foresite Capital Management II
California
$9.02M +$5.05M +171,824 New
BIT
15
BlackRock Institutional Trust
California
$7.27M +$701K +23,856 +21%
DCM
16
DAFNA Capital Management
California
$7.13M -$473K -16,117 -11%
DMK
17
David M. Knott
$6.74M – – –
State Street
18
State Street
Massachusetts
$6.41M -$918K -31,278 -20%
Lazard Asset Management
19
Lazard Asset Management
New York
$6.13M +$3.43M +116,860 New
SFM
20
Sphera Funds Management
Israel
$5.78M -$1.62M -55,000 -33%
Northern Trust
21
Northern Trust
Illinois
$5.46M -$81.8K -2,786 -3%
CAM
22
Cormorant Asset Management
Massachusetts
$5.25M – – –
BC
23
Broadfin Capital
New York
$5.25M +$2.94M +100,000 New
PI
24
Putnam Investments
Massachusetts
$5.24M -$1.88M -63,900 -39%
CWG
25
C WorldWide Group
Denmark
$5.14M +$2.88M +97,921 New
1
2 3 4 5

ASPX Hedge Fund Activity: Q4 2014 in Review

89 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q4 2014, worth a combined $773M — up 149% from $310M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ASPX positions and 19 closed out — a net gain of 18 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $42.7M. The largest seller was Ameriprise, cutting an estimated $7.57M.

  • 89 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q4 2014, up from 71 in Q3 2014.
  • Funds reported $773M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, up 149% quarter-over-quarter.
  • 37 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 19 closed out, a net change of +18 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Fidelity Investments, an estimated $42.7M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Ameriprise, an estimated $7.57M sold.

Based on aggregated 13F filings for Q4 2014.